Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
CO3-H5253 | Human | Human Complement component 3 Protein, Fc Tag (MALS verified) |
|
||
CO3-H82E8 | Human | Biotinylated Human Complement C3 Protein, His,Avitag™ (MALS verified) |
|
||
CO3-C52H5 | Cynomolgus | Cynomolgus Complement C3 Protein, His Tag (MALS verified) |
|
||
CO3-M52H4 | Mouse | Mouse Complement C3 Protein, His Tag (MALS verified) |
|
||
CO3-H52H3 | Human | Human Complement C3 Protein, His Tag (MALS verified) |
|
Immobilized Biotinylated Human Complement C3, His,Avitag (Cat. No. CO3-H82E8) at 1 μg/mL (100 μL/well)on streptavidin precoated (0.5 μg/well) plate can bind Human Anti-C3,Human IgG1 Human Kappa with a linear range of 0.1-4 ng/mL (QC tested).
The purity of Human Complement component 3 Protein, Fc Tag (Cat. No. CO3-H5253) is more than 85% and the molecular weight of this protein is around 390-440 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Pegcetacoplan | APL-2 | Approved | Apellis Pharmaceuticals Inc | Aspaveli, Empaveli | United States | Hemoglobinuria, Paroxysmal | Apellis Pharmaceuticals Inc | 2021-05-14 | Motor Neuron Disease; Rejection of renal transplantation; Hemoglobinuria, Paroxysmal; Glomerulonephritis, IGA; Thrombotic Microangiopathies; Glomerulonephritis, Membranous; Lupus Nephritis; Glomerulonephritis, Membranoproliferative; Anemia, Hemolytic, Autoimmune; Geographic Atrophy; Glomerulonephritis; Amyotrophic Lateral Sclerosis; Macular Degeneration | Details |
Pegcetacoplan | APL-2 | Approved | Apellis Pharmaceuticals Inc | Aspaveli, Empaveli | United States | Hemoglobinuria, Paroxysmal | Apellis Pharmaceuticals Inc | 2021-05-14 | Motor Neuron Disease; Rejection of renal transplantation; Hemoglobinuria, Paroxysmal; Glomerulonephritis, IGA; Thrombotic Microangiopathies; Glomerulonephritis, Membranous; Lupus Nephritis; Glomerulonephritis, Membranoproliferative; Anemia, Hemolytic, Autoimmune; Geographic Atrophy; Glomerulonephritis; Amyotrophic Lateral Sclerosis; Macular Degeneration | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Efdamrofusp alfa | IBI-302 | Phase 3 Clinical | AP Biosciences Inc | Diabetic macular oedema; Wet Macular Degeneration; Macular Degeneration; Plaque psoriasis | Details |
APL-9 | Phase 2 Clinical | Apellis Pharmaceuticals Inc | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Coronavirus Infections; Severe Acute Respiratory Syndrome | Details | |
NGM-621 | NGM-621 | Phase 2 Clinical | Ngm Biopharmaceuticals Inc | Coronavirus Disease 2019 (COVID-19); Geographic Atrophy | Details |
Compstatin 40 | AMY-101 | Phase 2 Clinical | University Of Pennsylvania | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Gingivitis | Details |
ARO-C3 | ARO-C3; ARO-C-3 | Phase 2 Clinical | Arrowhead Pharmaceuticals Inc | Glomerulonephritis, IGA; Glomerulonephritis | Details |
CG-001 | CG-001 | Phase 1 Clinical | Chengdu Konjin Co Ltd | Hemoglobinuria, Paroxysmal; Autoimmune Diseases | Details |
ADX-097 | ADX-097 | Phase 1 Clinical | Q32 Bio Inc | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Glomerulonephritis, IGA; Kidney Diseases; Nephrosis, Lipoid; Lupus Nephritis; Inflammation; Autoimmune Diseases of the Nervous System | Details |
APL-3007 | APL-3007 | Phase 1 Clinical | Apellis Pharmaceuticals Inc | Details | |
SGB-9768 | SGB-9768 | Phase 1 Clinical | Suzhou Sanegene Biopharmaceuticals Ltd, Sanegene Bio New Zealand Ltd | Details | |
NM3086 | NM3086; NM-3086 | Phase 1 Clinical | NovelMed Therapeutics Inc | Hemoglobinuria, Paroxysmal | Details |
LP-005 | LP-005; RX-001 | Phase 1 Clinical | Longbio Pharma (Suzhou) Co Ltd | Peripheral Nervous System Diseases; Myasthenia Gravis; Hemoglobinuria, Paroxysmal; Kidney Diseases; Amyotrophic Lateral Sclerosis | Details |
Efdamrofusp alfa | IBI-302 | Phase 3 Clinical | AP Biosciences Inc | Diabetic macular oedema; Wet Macular Degeneration; Macular Degeneration; Plaque psoriasis | Details |
APL-9 | Phase 2 Clinical | Apellis Pharmaceuticals Inc | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Coronavirus Infections; Severe Acute Respiratory Syndrome | Details | |
NGM-621 | NGM-621 | Phase 2 Clinical | Ngm Biopharmaceuticals Inc | Coronavirus Disease 2019 (COVID-19); Geographic Atrophy | Details |
Compstatin 40 | AMY-101 | Phase 2 Clinical | University Of Pennsylvania | Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Gingivitis | Details |
ARO-C3 | ARO-C3; ARO-C-3 | Phase 2 Clinical | Arrowhead Pharmaceuticals Inc | Glomerulonephritis, IGA; Glomerulonephritis | Details |
CG-001 | CG-001 | Phase 1 Clinical | Chengdu Konjin Co Ltd | Hemoglobinuria, Paroxysmal; Autoimmune Diseases | Details |
ADX-097 | ADX-097 | Phase 1 Clinical | Q32 Bio Inc | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Glomerulonephritis, IGA; Kidney Diseases; Nephrosis, Lipoid; Lupus Nephritis; Inflammation; Autoimmune Diseases of the Nervous System | Details |
APL-3007 | APL-3007 | Phase 1 Clinical | Apellis Pharmaceuticals Inc | Details | |
SGB-9768 | SGB-9768 | Phase 1 Clinical | Suzhou Sanegene Biopharmaceuticals Ltd, Sanegene Bio New Zealand Ltd | Details | |
NM3086 | NM3086; NM-3086 | Phase 1 Clinical | NovelMed Therapeutics Inc | Hemoglobinuria, Paroxysmal | Details |
LP-005 | LP-005; RX-001 | Phase 1 Clinical | Longbio Pharma (Suzhou) Co Ltd | Peripheral Nervous System Diseases; Myasthenia Gravis; Hemoglobinuria, Paroxysmal; Kidney Diseases; Amyotrophic Lateral Sclerosis | Details |
This web search service is supported by Google Inc.